Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SOAT2 | O75908 | 2/20 | 0.57 |
| ▸ | SOAT1 | P35610 | 2/20 | 0.57 |
| ▸ | CTSS | P25774 | 1/20 | 0.56 |
| ▸ | CTSK | P43235 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | GNPAT | O15228 | 1/20 | 0.50 |
| ▸ | PAM | P19021 | 1/20 | 0.50 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9679315 | 0.91 | SOAT2 (0.59) | SOAT2SOAT1LMNAKMT2A | |
| SCHEMBL9679311 | 0.91 | SOAT2 (0.59) | SOAT2SOAT1LMNAKMT2A | |
| SCHEMBL9680770 | 0.87 | LMNA (0.62) | SOAT2SOAT1CTSSCTSKLMNA | |
| SCHEMBL9680183 | 0.85 | ANPEP (0.63) | SOAT2SOAT1 | |
| SCHEMBL9681111 | 0.85 | SOAT2 (0.53) | SOAT2SOAT1LMNAKMT2A | |
| SCHEMBL9679723 | 0.84 | SOAT2 (0.57) | SOAT2SOAT1LMNAKMT2A | |
| SCHEMBL9851026 | 0.84 | CTSL (0.61) | CTSSCTSK | |
| SCHEMBL9678826 | 0.84 | CTSS (0.59) | CTSSCTSKGNPATPAMPSMB8 | |
| SCHEMBL9681008 | 0.83 | PSMB5 (0.59) | SOAT2SOAT1 | |
| SCHEMBL9679671 | 0.83 | CTSS (0.58) | CTSSCTSKGNPATPAMPSMB8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0415413-A1 | Acat inhibitors | WARNER-LAMBERT COMPANY (US) | 1991-03-06 | — | — | EP | claimed |
| US-5153226-A | Administering as anticholesterol agents, for atherosclerosis | WARNER-LAMBERT COMPANY (US) | 1992-10-06 | — | — | US | disclosed |
| EP-0415413-A1 | Acat inhibitors | WARNER-LAMBERT COMPANY (US) | 1991-03-06 | — | — | EP | disclosed |